Obesity

The Next Public Health Challenge

Research output: Contribution to journalEditorial

Abstract

In the past few decades, life expectancy has increased dramatically in developed countries, and many people now have better quality of life at a chronological age that 40 years ago would have seemed unimaginable. We have added both years to life and life to years. These changes are attributable to improved understanding of disease processes and their management. Pharmacotherapies and pharmacists have contributed to these improvements. However, this is only part of the story: much of the changed demographic profile comes from a better understanding of how we can prevent disease through public health approaches to improved lifestyles. In the United Kingdom, smoking prevalence, once 50%,1 is now 16%,2 and in many subsets of the population, it is even lower. Smoking prevalence in Canada is also at an all-time low, an estimated 13%.3 Smoking reductions have translated into reductions in coronary heart disease and cancers; indeed, smoking cessation has been labelled the most cost-effective health intervention there is. Pharmacists have contributed greatly to this cultural change.
Original languageEnglish
Pages (from-to)331-332
Number of pages2
JournalThe Canadian Journal of Hospital Pharmacy
Volume70
Issue number5
DOIs
Publication statusPublished - 8 Nov 2017

Fingerprint

Public health
Public Health
Obesity
Smoking
Pharmacists
Drug therapy
Heart Neoplasms
Smoking Cessation
Life Expectancy
Developed Countries
Health Care Costs
Canada
Coronary Disease
Life Style
Quality of Life
Demography
Health
Drug Therapy
Population
Costs

Keywords

  • Editorial

Cite this

Obesity : The Next Public Health Challenge. / Bond, Christine M.

In: The Canadian Journal of Hospital Pharmacy, Vol. 70, No. 5, 08.11.2017, p. 331-332.

Research output: Contribution to journalEditorial

@article{e5370720dcc74033823d6eb773df6495,
title = "Obesity: The Next Public Health Challenge",
abstract = "In the past few decades, life expectancy has increased dramatically in developed countries, and many people now have better quality of life at a chronological age that 40 years ago would have seemed unimaginable. We have added both years to life and life to years. These changes are attributable to improved understanding of disease processes and their management. Pharmacotherapies and pharmacists have contributed to these improvements. However, this is only part of the story: much of the changed demographic profile comes from a better understanding of how we can prevent disease through public health approaches to improved lifestyles. In the United Kingdom, smoking prevalence, once 50{\%},1 is now 16{\%},2 and in many subsets of the population, it is even lower. Smoking prevalence in Canada is also at an all-time low, an estimated 13{\%}.3 Smoking reductions have translated into reductions in coronary heart disease and cancers; indeed, smoking cessation has been labelled the most cost-effective health intervention there is. Pharmacists have contributed greatly to this cultural change.",
keywords = "Editorial",
author = "Bond, {Christine M}",
year = "2017",
month = "11",
day = "8",
doi = "10.4212/cjhp.v70i5.1692",
language = "English",
volume = "70",
pages = "331--332",
journal = "The Canadian Journal of Hospital Pharmacy",
issn = "0008-4123",
publisher = "Canadian Society of Hospital Pharmacists",
number = "5",

}

TY - JOUR

T1 - Obesity

T2 - The Next Public Health Challenge

AU - Bond, Christine M

PY - 2017/11/8

Y1 - 2017/11/8

N2 - In the past few decades, life expectancy has increased dramatically in developed countries, and many people now have better quality of life at a chronological age that 40 years ago would have seemed unimaginable. We have added both years to life and life to years. These changes are attributable to improved understanding of disease processes and their management. Pharmacotherapies and pharmacists have contributed to these improvements. However, this is only part of the story: much of the changed demographic profile comes from a better understanding of how we can prevent disease through public health approaches to improved lifestyles. In the United Kingdom, smoking prevalence, once 50%,1 is now 16%,2 and in many subsets of the population, it is even lower. Smoking prevalence in Canada is also at an all-time low, an estimated 13%.3 Smoking reductions have translated into reductions in coronary heart disease and cancers; indeed, smoking cessation has been labelled the most cost-effective health intervention there is. Pharmacists have contributed greatly to this cultural change.

AB - In the past few decades, life expectancy has increased dramatically in developed countries, and many people now have better quality of life at a chronological age that 40 years ago would have seemed unimaginable. We have added both years to life and life to years. These changes are attributable to improved understanding of disease processes and their management. Pharmacotherapies and pharmacists have contributed to these improvements. However, this is only part of the story: much of the changed demographic profile comes from a better understanding of how we can prevent disease through public health approaches to improved lifestyles. In the United Kingdom, smoking prevalence, once 50%,1 is now 16%,2 and in many subsets of the population, it is even lower. Smoking prevalence in Canada is also at an all-time low, an estimated 13%.3 Smoking reductions have translated into reductions in coronary heart disease and cancers; indeed, smoking cessation has been labelled the most cost-effective health intervention there is. Pharmacists have contributed greatly to this cultural change.

KW - Editorial

U2 - 10.4212/cjhp.v70i5.1692

DO - 10.4212/cjhp.v70i5.1692

M3 - Editorial

VL - 70

SP - 331

EP - 332

JO - The Canadian Journal of Hospital Pharmacy

JF - The Canadian Journal of Hospital Pharmacy

SN - 0008-4123

IS - 5

ER -